Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
Ariel Zisman(University of Miami), Barbara B. Kahn(Beth Israel Deaconess Medical Center), E. Dale Abel(University of Utah), Bradford B. Lowell(Beth Israel Deaconess Medical Center), Antti Virkamäki(Finnish Diabetes Association), Laurie J. Goodyear(Joslin Diabetes Center), Jørgen F. P. Wojtaszewski(University of Copenhagen), C. Ronald Kahn(Joslin Diabetes Center), Franck Mauvais‐Jarvis(Northwestern University), M. Dodson Michael(Joslin Diabetes Center), Odile D. Peroni(Beth Israel Deaconess Medical Center), Michael F. Hirshman(Joslin Diabetes Center)
Cited by 755
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k